Semler Scientific purchased 111 Bitcoins worth $10 million between February and April 2025

The medical technology company is funding these purchases primarily by selling new stock.

Semler Scientific has purchased 111 Bitcoins for a total of $10 million between February and April 2025.

For a limited time, get 50% off any plan and use code SAVEBIG.

Craving the latest in AI, tech breakthroughs, and futuristic innovation?

Subscribe to Greenbot's Bitcoins at an average price of $90,124 per coin. The medical technology company is funding these purchases primarily by selling new stock. The company’s overall Bitcoin treasury now has an average purchase price of $87,929 per coin.

The Santa Clara healthcare firm, which trades under SMLR on Nasdaq, is also planning to raise $75 million through the issuance of convertible senior notes.

"You can sell or stop if you don't like what we've done with Bitcoin. We are a public company; you have that right to sell or stop," said Chairman Eric Semler to investors at a recent event.

Semler Scientific is disclosing its Bitcoin purchases in accordance with Generally Accepted Accounting Principles (GAAP). The company's approach is similar to that of Strategy (formerly MicroStrategy), whose aggressive Bitcoin buying has driven its stock price up by over 350% in 2024. Several public companies have followed this model, and corporate Bitcoin holdings are now worth about $71 billion worldwide.

The success of Semler Scientific's Bitcoin strategy is measured by "BTC Yield," which reached 23.5% year-to-date as of April 24. This metric compares the company's Bitcoin holdings to its total possible shares outstanding.

"Semler Scientific uses BTC Yield as a KPI to help assess the performance of its strategy of acquiring bitcoin in a manner Semler Scientific believes is accretive to stockholders," the company stated in its press release.

However, despite growing its Bitcoin reserves, Semler faces some financial challenges. The company reported a preliminary operational loss of $1.3-1.5 million for the first quarter of 2025, with revenues between $8.8-8.9 million. The loss was partly due to legal fees related to a U.S. Department of Justice investigation.

Semler Scientific has tentatively agreed to a $29.75 million settlement with the DOJ, although this deal is not final. The company also reported an unrealized loss of approximately $41.8 million due to fluctuations in the value of Bitcoin.

The firm's main business centers on making diagnostic tools for chronic diseases. Their main product is QuantaFlo, a test that measures blood flow to help diagnose heart disease.

Semler Scientific ranks as the 14th largest corporate holder of Bitcoin globally.